North America Syringe Infusion Pumps Market 2030: Driving Growth in Chronic Disease Management
The North America syringe infusion pumps market was valued at USD 645.1 million in 2024 and is expected to grow to USD 1.04 billion by 2030, with a compound annual growth rate (CAGR) of 8.4% between 2025 and 2030. The market growth in this region is primarily driven by the increasing prevalence of chronic diseases such as cancer, cardiovascular disorders, diabetes, and respiratory illnesses. These conditions require precise and continuous medication delivery, which syringe infusion pumps enable by accurately dosing critical drugs like chemotherapy agents and insulin. Since about six in ten adults in North America suffer from at least one chronic condition, the demand for dependable infusion devices in both hospital and outpatient care settings continues to rise, highlighting the vital role of these pumps in patient management. The growing number of surgical procedures and intensive care unit (ICU) admissions further supports the syringe infusion pump market expansion. These pumps are...